Serum CD300LG levels were also positively associated with fat mass and fat free mass, and negatively associated with glucometabolic traits, including serum glucose levels, Hb1Ac, and the risk of having type 2 diabetes (Table 1). The gene discussed is CD300LG; the disease is type 2 diabetes mellitus.